Janssen Pharmaceuticals focuses on complex medical challenges across six therapeutic areas:
Cardiovascular & Metabolism
Infectious Diseases & Vaccines
Janssen also makes an HIV medication that contains darunavir (a protease inhibitor) and cobicistat, which is being tested for activity against COVID-19.
The company is also working on a vaccine to prevent COVID-19.